Global transcriptional profiles of Mycobacterium tuberculosis treated with plumbagin

World Journal of Microbiology and Biotechnology

Volumn 27, Issue 10, 2011, Pages 2261-2269

  Ye, Haiqing ^a   Liu, Zengshan ^a   Guo, Aizhen ^c   Liang, Junchao ^a   Guo, Na ^a   Zeng, Fanli ^d   Liu, Liqiang ^c   Li, Lei ^a   Jin, Jing ^a   Wu, Xiuping ^a   Li, Yang ^a   Liu, Mingyuan ^a   Jin, Qi ^b   Yu, Lu ^a  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^d JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antimycobacterial; Microarray; Mycobacterium tuberculosis; Plumbagin

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTI-MYCOBACTERIAL; CELL ENVELOPES; M. TUBERCULOSIS; MULTIGENE FAMILIES; MYCOBACTERIUM TUBERCULOSIS; NATURAL PLANTS; OLIGONUCLEOTIDE MICROARRAY; PLUMBAGIN; RESISTANT STRAINS; RESPONSE MECHANISMS; TRANSCRIPTIONAL RESPONSE; TRANSCRIPTOMICS;

MICROARRAYS; OLIGONUCLEOTIDES;

GENES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80052850764     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-011-0689-3     Document Type: Article

References (35)

1. Anurag M, Dash D (2009) Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis. Mol Biosyst 5(12): 1752-1757.
2. Bendtsen JD, Nielsen H, Widdick D et al (2005) Prediction of twin-arginine signal peptides. BMC Bioinform 6: 167.
3. Borges-Argáez R, Canche-Chay CI, Peña-Rodríguez LM et al (2007) Antimicrobial activity of Diospyros anisandra. Fitoterapia 78(5): 370-372.
4. Camacho-Corona Mdel R, Ramírez-Cabrera MA, Santiago OG et al (2008) Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytother Res 22(1): 82-85.
5. Cantrell CL, Franzblau SG, Fischer NH (2001) Antimycobacterial plant terpenoids. Planta Med 67(8): 685-694.
6. Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
7. Dzoyem JP, Tangmouo JG, Lontsi D et al (2007) In vitro antifungal activity of extract and plumbagin from the stem bark of Diospyros crassiflora Hiern (Ebenaceae). Phytother Res 21(7): 671-674.
8. Ellis RJ, Hartl FU (1996) Protein folding in the cell: competing models of chaperonin function. FASEB J 10: 20-26.
9. Emerson JE, Stabler RA, Wren BW et al (2008) Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J Med Microbiol 57: 757-764.
10. Franzblau SG, Witzig RS, McLaughlin JC et al (1998) Rapid low-technology MIC determination with clinical, Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36(2): 362-366.
11. Gragerov A, Nudler E, Komissarova N et al (1992) Cooperation of GroEL/GroES and DnaK/DnaJ heat shock proteins in preventing protein misfolding in Escherichia coli. Proc Natl Acad Sci U S A 89: 10341-10344.
12. Grassi M, Volpe E, Colizzi V et al (2006) An improved, real-time PCR assay for the detection of GC-rich and low abundance templates of Mycobacterium tuberculosis. J Microbiol Methods 64(3): 406-410.
13. Graubner W, Schierhorn A, Brüser T (2007) DnaK plays a pivotal role in Tat targeting of CueO and functions beside SlyD as a general Tat signal binding chaperone. J Biol Chem 282: 7116-7124.
14. Hickey TB, Thorson LM, Speert DP et al (2009) Mycobacterium tuberculosis Cpn60. 2 and DnaK are located on the bacterial surface, where Cpn60. 2 facilitates efficient bacterial association with macrophages. Infect Immun 77: 3389-3401.
15. Hsu YL, Cho CY, Kuo PL et al (2006) Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther 318: 484-494.
16. Jiménez-Arellanes A, Meckes M, Ramírez R et al (2003) Activity against multidrug-resistant Mycobacterium tuberculosis in mexican plants used to treat respiratory diseases. Phytother Res 17(8): 903-908.
17. Karboul A, Mazza A, Gey van Pittius NC et al (2008) Frequent homologous recombination events in Mycobacterium tuberculosis PE/PPE multigene families: potential role in antigenic variability. J Bacteriol 190(23): 7838-7846.
18. Kuete V, Tangmouo JG, Meyer JJ et al (2009) Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp. Int J Antimicrob Agents 34: 322-325.
19. Kuo PL, Hsu YL, Cho CY (2006) Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 5: 3209-3921.
20. Li X, Liu N, Zhang H et al (2010) Synthesis and SAR studies of 1, 4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorg Med Chem Lett 20(21): 6306-6309.
21. Liu TT, Lee RE, Barker KS et al (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49: 2226-2236.
22. Mathew R, Kruthiventi AK, Prasad JV et al (2010) Inhibition of mycobacterial growth by plumbagin derivatives. Chem Biol Drug Des 76: 34-42.
23. Mehra S, Kaushal D (2009) Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor. J Bacteriol 191(12): 3965-3980.
24. Micklinghoff JC, Breitinger KJ, Schmidt M et al (2009) Role of the transcriptional regulator RamB (Rv0465c) in the control of the glyoxylate cycle in Mycobacteriumtuberculosis. J Bacteriol 191(23): 7260-7269.
25. Provvedi R, Boldrin F, Falciani F et al (2009) Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology 155: 1093-1102.
26. Sandur SK, Ichikawa H, Sethi G et al (2006) Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) suppresses NF-kappa B-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. Biol Chem 281: 17023-17033.
27. Shimono N, Morici L, Casali N et al (2003) Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci USA 100: 15918-15923.
28. Slayden RA, Knudson DL, Belisle JT (2006) Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Microbiology 152(Pt 6): 1789-1797.
29. Strong M, Sawaya MR, Wang S et al (2006) Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103(21): 8060-8065.
30. 2 biosynthesis. J Biol Chem 278(43): 42352-42360.
31. van Rie A, Warren R, Richardson M et al (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 341(16): 1174-1179.
32. Waddell SJ, Stabler RA, Laing K et al (2004) The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis 84: 263-274.
33. Wang D, Yu L, Xiang H et al (2008a) Global transcriptional profiles of Staphylococcus aureus treated with berberine chloride. FEMS Microbiol Lett 279: 217-225.
34. Wang CC, Chiang YM, Sung SC et al (2008b) Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375. S2 cells. Cancer Lett 259(1): 82-98.
35. Ward SK, Hoye EA, Talaat AM (2008) The global responses of Mycobacterium tuberculosis to physiological levels of copper. J Bacteriol 190: 2939-2946.